Activity of the Aurora Kinase Inhibitor VX-680 against Bcr/Abl-Positive Acute Lymphoblastic Leukemias

Fei Fei(University of Southern California), Nora Heisterkamp(City of Hope)
Molecular Cancer Therapeutics
April 14, 2010
Cited by 37


Related Papers